Compared with the normoalbuminuric group, the moderately increased albuminuria group were, in general, significantly older, and had a significantly higher percentage of participants with BMI ≥ 25 kg/m2, diabetes, hypertension, dyslipidemia, and mild liver disorder (AST ≥ 31 U/L or ALT ≥ 31 U/L or GGT ≥ 51 U/L). The gene discussed is GPT; the disease is liver disorder.